BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 9052984)

  • 1. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
    Kovar H; Aryee DN; Jug G; Henöckl C; Schemper M; Delattre O; Thomas G; Gadner H
    Cell Growth Differ; 1996 Apr; 7(4):429-37. PubMed ID: 9052984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
    Fukuma M; Okita H; Hata J; Umezawa A
    Oncogene; 2003 Jan; 22(1):1-9. PubMed ID: 12527902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.
    Sorensen PH; Lessnick SL; Lopez-Terrada D; Liu XF; Triche TJ; Denny CT
    Nat Genet; 1994 Feb; 6(2):146-51. PubMed ID: 8162068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
    Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ
    Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias.
    Yi H; Fujimura Y; Ouchida M; Prasad DD; Rao VN; Reddy ES
    Oncogene; 1997 Mar; 14(11):1259-68. PubMed ID: 9178886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.
    Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T
    Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
    Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
    Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EWS/Fli-1 chimeric protein is a transcriptional activator.
    Ohno T; Rao VN; Reddy ES
    Cancer Res; 1993 Dec; 53(24):5859-63. PubMed ID: 7503813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new member of the ETS family fused to EWS in Ewing tumors.
    Peter M; Couturier J; Pacquement H; Michon J; Thomas G; Magdelenat H; Delattre O
    Oncogene; 1997 Mar; 14(10):1159-64. PubMed ID: 9121764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene.
    Lessnick SL; Braun BS; Denny CT; May WA
    Oncogene; 1995 Feb; 10(3):423-31. PubMed ID: 7845667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids.
    Athanasiou M; LeGallic L; Watson DK; Blair DG; Mavrothalassitis G
    Cancer Gene Ther; 2000 Aug; 7(8):1188-95. PubMed ID: 10975680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.
    Tanaka K; Iwakuma T; Harimaya K; Sato H; Iwamoto Y
    J Clin Invest; 1997 Jan; 99(2):239-47. PubMed ID: 9005992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors.
    Nishimori H; Sasaki Y; Yoshida K; Irifune H; Zembutsu H; Tanaka T; Aoyama T; Hosaka T; Kawaguchi S; Wada T; Hata J; Toguchida J; Nakamura Y; Tokino T
    Oncogene; 2002 Nov; 21(54):8302-9. PubMed ID: 12447693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein.
    Rao VN; Ohno T; Prasad DD; Bhattacharya G; Reddy ES
    Oncogene; 1993 Aug; 8(8):2167-73. PubMed ID: 8336942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EAT-2 is a novel SH2 domain containing protein that is up regulated by Ewing's sarcoma EWS/FLI1 fusion gene.
    Thompson AD; Braun BS; Arvand A; Stewart SD; May WA; Chen E; Korenberg J; Denny C
    Oncogene; 1996 Dec; 13(12):2649-58. PubMed ID: 9000139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.
    Wang M; Xie Y; Girnita L; Nilsson G; Dricu A; Wejde J; Larsson O
    Exp Cell Res; 1999 Jan; 246(1):38-46. PubMed ID: 9882513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
    Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
    Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermal tumors of childhood.
    Sorensen PH; Liu XF; Delattre O; Rowland JM; Biggs CA; Thomas G; Triche TJ
    Diagn Mol Pathol; 1993 Sep; 2(3):147-57. PubMed ID: 7506981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties.
    Bertolotti A; Bell B; Tora L
    Oncogene; 1999 Dec; 18(56):8000-10. PubMed ID: 10637511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene.
    Sorensen PH; Shimada H; Liu XF; Lim JF; Thomas G; Triche TJ
    Cancer Res; 1995 Mar; 55(6):1385-92. PubMed ID: 7882340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.